PL2376479T3 - Podstawione furanokarboksyamidy i ich zastosowanie - Google Patents

Podstawione furanokarboksyamidy i ich zastosowanie

Info

Publication number
PL2376479T3
PL2376479T3 PL09803727.8T PL09803727T PL2376479T3 PL 2376479 T3 PL2376479 T3 PL 2376479T3 PL 09803727 T PL09803727 T PL 09803727T PL 2376479 T3 PL2376479 T3 PL 2376479T3
Authority
PL
Poland
Prior art keywords
furancarboxamides
substituted
substituted furancarboxamides
Prior art date
Application number
PL09803727.8T
Other languages
English (en)
Inventor
Kai Thede
Susanne Greschat
Steffen Wildum
Daniela Paulsen
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of PL2376479T3 publication Critical patent/PL2376479T3/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Communicable Diseases (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PL09803727.8T 2008-12-17 2009-12-16 Podstawione furanokarboksyamidy i ich zastosowanie PL2376479T3 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE102008062878A DE102008062878A1 (de) 2008-12-17 2008-12-17 Substituierte Furancarboxamide und ihre Verwendung

Publications (1)

Publication Number Publication Date
PL2376479T3 true PL2376479T3 (pl) 2016-09-30

Family

ID=41796256

Family Applications (1)

Application Number Title Priority Date Filing Date
PL09803727.8T PL2376479T3 (pl) 2008-12-17 2009-12-16 Podstawione furanokarboksyamidy i ich zastosowanie

Country Status (14)

Country Link
US (1) US8324268B2 (pl)
EP (1) EP2376479B1 (pl)
CA (1) CA2747640A1 (pl)
CY (1) CY1117577T1 (pl)
DE (1) DE102008062878A1 (pl)
DK (1) DK2376479T3 (pl)
ES (1) ES2574639T3 (pl)
HR (1) HRP20160578T1 (pl)
HU (1) HUE027605T2 (pl)
PL (1) PL2376479T3 (pl)
PT (1) PT2376479E (pl)
SI (1) SI2376479T1 (pl)
SM (1) SMT201600217B (pl)
WO (1) WO2010075957A1 (pl)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9562019B2 (en) * 2006-12-21 2017-02-07 Sloan-Kettering Institute For Cancer Research Substituted pyridazines as EGFR and/or KRAS inhibitors
DE102008062863A1 (de) 2008-12-17 2010-06-24 Aicuris Gmbh & Co. Kg Substituierte (Thiophenyl-carbonyl)imidazolidinone und ihre Verwendung
US20210300939A1 (en) 2018-07-23 2021-09-30 Signalrx Pharmaceuticals, Inc. Single Molecule Compounds Providing Multi-Target Inhibition of BTK and Other Proteins and Methods of Use Thereof

Family Cites Families (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3806506A (en) * 1971-08-05 1974-04-23 Uniroyal Inc Furan derivatives,compositions thereof and methods for using same
DE3119796A1 (de) 1981-05-19 1982-12-23 Hoechst Ag, 6000 Frankfurt Substituierte tryptaminderivate von thienyloxpropanolaminen, verfahren zu ihrer herstellung, pharmazeutische praeparate auf basis dieser verbindungen sowie ihre verwendung
FR2538388B1 (fr) 1982-12-24 1985-06-21 Pharmuka Lab Nouveaux derives de naphtalene- ou azanaphtalenecarboxamide, leurs procedes de preparation et leur utilisation comme medicaments
US5591761A (en) 1993-05-20 1997-01-07 Texas Biotechnology Corporation Thiophenyl-, furyl-and pyrrolyl-sulfonamides and derivatives thereof that modulate the activity of endothelin
IL91418A (en) 1988-09-01 1997-11-20 Rhone Poulenc Agrochimie (hetero) cyclic amide derivatives, process for their preparation and fungicidal compositions containing them
PH27357A (en) 1989-09-22 1993-06-21 Fujisawa Pharmaceutical Co Pyrazole derivatives and pharmaceutical compositions comprising the same
US5571810A (en) * 1990-06-11 1996-11-05 Fujisawa Pharmaceutical Co., Ltd. Thiophene derivatives
GB9012936D0 (en) 1990-06-11 1990-08-01 Fujisawa Pharmaceutical Co Thiophene derivatives,processes for preparation thereof and pharmaceutical composition comprising the same
IL104311A (en) 1992-02-05 1997-07-13 Fujisawa Pharmaceutical Co Pyrazole derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same
FR2692575B1 (fr) 1992-06-23 1995-06-30 Sanofi Elf Nouveaux derives du pyrazole, procede pour leur preparation et compositions pharmaceutiques les contenant.
JPH084281B2 (ja) 1992-09-30 1996-01-17 橋本コーポレイション株式会社 オンフック後相手の声を拡声する電話装置
FR2728571B1 (fr) 1994-12-22 1997-01-31 Adir Nouveaux ethers d'oximes tricycliques, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent
US5696151A (en) * 1995-11-30 1997-12-09 Uniroyal Chemical Company, Inc. Compounds useful for the inhibition of the replication of HIV-1 and HIV-1 mutants
US6143780A (en) * 1999-09-17 2000-11-07 Uniroyal Chemical Company, Inc. N-arylmethylthioanilide compounds useful for the inhibition of the replication of HIV
KR20030014411A (ko) 2000-06-28 2003-02-17 아스트라제네카 아베 치환 퀴나졸린 유도체 및 저해제로서 그것의 용도
GB0113524D0 (en) 2001-06-04 2001-07-25 Hoffmann La Roche Pyrazole derivatives
US6930190B2 (en) 2001-08-01 2005-08-16 Basell Polyolefine Gmbh Process for the preparation of heterocyclic pentalene derivatives
CA2465207C (en) 2001-11-01 2011-01-04 Icagen, Inc. Pyrazole-amides and -sulfonamides
WO2004016592A1 (en) 2002-08-14 2004-02-26 Ppd Discovery, Inc. Prenylation inhibitors and methods of their synthesis and use
GB0221477D0 (en) 2002-09-16 2002-10-23 Pfizer Ltd Chemical compounds
GB0223232D0 (en) 2002-10-07 2002-11-13 Pfizer Ltd Chemical compounds
DK1562611T3 (da) * 2002-11-20 2006-12-04 Paradigm Therapeutics Ltd Heterocykliske siliciumforbindelser og deres anvendelse til behandling af sygdomme eller tilstande associeret med GnRH (gonadotropinfrigivende hormon)
WO2004050632A1 (en) 2002-12-02 2004-06-17 Fujisawa Pharmaceutical Co., Ltd. Pyrazole derivatives useful as cox-i inhibitors
TW200505447A (en) 2003-02-07 2005-02-16 Daiichi Seiyaku Co Pyrazole derivative
EP1599476B1 (en) 2003-02-27 2009-10-14 Neurosearch A/S Novel diazabicyclic aryl derivatives
FR2856683A1 (fr) 2003-06-25 2004-12-31 Sanofi Synthelabo Derives de 4-cyanopyrazole-3-carboxamide, leur preparation et leur application en therapeutique
GB0315657D0 (en) 2003-07-03 2003-08-13 Astex Technology Ltd Pharmaceutical compounds
US20050026968A1 (en) 2003-07-14 2005-02-03 University Of Tennessee Research Foundation Heterocyclic amides with anti-tuberculosis activity
US7220772B2 (en) 2003-09-05 2007-05-22 Pfizer, Inc. Pyrazole derivatives
FR2860792B1 (fr) 2003-10-10 2006-02-24 Sanofi Synthelabo Derives de thiophene-2-carboxamide, leur preparation et leur application en therapeutique
AU2005214130B2 (en) 2004-02-20 2008-03-06 Astrazeneca Ab 3-substituted 1,5-diphenylpyrazole derivatives useful as CB1 modulators
EP1762568A1 (en) 2004-07-01 2007-03-14 Daiichi Pharmaceutical Co., Ltd. Pyrazole derivatives
GB0417910D0 (en) 2004-08-11 2004-09-15 Novartis Ag Organic compounds
JP4942654B2 (ja) 2004-08-23 2012-05-30 イーライ リリー アンド カンパニー ヒスタミンh3受容体薬剤、製剤及び治療的使用
DE102004054666A1 (de) 2004-11-12 2006-05-18 Bayer Cropscience Gmbh Substituierte Pyrazol-3-carboxamide, Verfahren zur Herstellung und Verwendung als Herbizide und Pflanzenwachstumsregulatoren
JP2008523072A (ja) 2004-12-07 2008-07-03 ルーカス ファーマシューティカルズ, インコーポレイテッド タンパク質キナーゼの阻害剤
WO2006062982A2 (en) 2004-12-07 2006-06-15 Locus Pharmaceuticals, Inc. Urea inhibitors of map kinases
EP1831231A1 (en) 2004-12-15 2007-09-12 AstraZeneca AB Nicotinic acetylcholine receptor ligands
EA200701930A1 (ru) 2005-03-10 2008-02-28 Байер Фармасьютикалс Корпорейшн Производные пиримидина для лечения гиперпролиферативных нарушений
KR20080028964A (ko) 2005-06-27 2008-04-02 엑셀리시스, 인코포레이티드 피라졸계 lxr 변조제
EP1743637A1 (en) 2005-07-15 2007-01-17 Laboratorios Del Dr. Esteve, S.A. Use of substituted pyrazole compounds and combinations thereof for the treatment of the metabolic syndrome
ES2326723B1 (es) 2005-07-15 2010-05-11 Laboratorios Del Dr. Esteve, S.A. Uso de compuestos de pirazol sustituidos y combinaciones de los mismos para el tratamiento del sindrome metabolico.
GB0516661D0 (en) 2005-08-13 2005-09-21 Astrazeneca Ab Therapeutic agents
RU2009117653A (ru) 2006-10-12 2010-11-20 Янссен Фармацевтика Нв (Be) Применение производных замещенного пиразинона в качестве лекарственного средства
US9562019B2 (en) 2006-12-21 2017-02-07 Sloan-Kettering Institute For Cancer Research Substituted pyridazines as EGFR and/or KRAS inhibitors
GB0701426D0 (en) 2007-01-25 2007-03-07 Univ Sheffield Compounds and their use
DE102008015032A1 (de) 2008-03-17 2009-09-24 Aicuris Gmbh & Co. Kg Substituierte Pyrazolamide und ihre Verwendung
DE102008015033A1 (de) 2008-03-17 2009-09-24 Aicuris Gmbh & Co. Kg Substituierte (Pyrazolyl-carbonyl)imidazolidinone und ihre Verwendung

Also Published As

Publication number Publication date
US8324268B2 (en) 2012-12-04
PT2376479E (pt) 2016-06-07
WO2010075957A1 (de) 2010-07-08
SMT201600217B (it) 2016-08-31
EP2376479A1 (de) 2011-10-19
SI2376479T1 (sl) 2016-07-29
HRP20160578T1 (hr) 2016-07-15
CA2747640A1 (en) 2010-07-08
CY1117577T1 (el) 2017-04-26
DK2376479T3 (en) 2016-06-13
EP2376479B1 (de) 2016-03-02
HUE027605T2 (en) 2016-10-28
ES2574639T3 (es) 2016-06-21
US20120022059A1 (en) 2012-01-26
DE102008062878A1 (de) 2010-06-24

Similar Documents

Publication Publication Date Title
IL214614A0 (en) Substituted 2-acetamido-5-aryl-1,2,4-triazolones and use thereof
IL210804A (en) Benzylidenehydrazides and their uses
ZA201007816B (en) Novel substituted pyridin-2-ones and pyridazin-3-ones
GB0917044D0 (en) Agents, uses and methods
GB0917054D0 (en) Agents, uses and methods
PL2354161T3 (pl) Przeciwciało anty -NR10 i jego zastosowanie
EP2307344A4 (en) OXABICYCLOHEPTANES AND OXABICYCLOHEPTENES, PREPARATION AND USE THEREOF
GB0818241D0 (en) Compounds and their use
GB0803352D0 (en) Oligopeptidic compounds and uses thereof
SI2344449T1 (sl) Aril-fenil-sulfonamido-cikloalkilne spojine in njihova uporaba
IL208081A0 (en) Amido - thiophene compounds and their use
ZA201007395B (en) Aryl-quinolyl compounds and their use
EP2291377A4 (en) IMIDAZOPYRIMIDINONE AND ITS USES
ZA201103456B (en) Leukolectins and uses thereof
EP2247601A4 (en) THIAZOPYRIMIDINONE AND APPLICATIONS THEREOF
GB0812012D0 (en) Use
SI2354161T1 (sl) Anti-NR10 protitelo in njegova uporaba
IL209718A0 (en) Substituted 7-sulfanylmethyl, 7-sulfinylmethyl and 7-sulfonylmethyl indoles and use thereof
SI2376479T1 (sl) Substituirani furankarboksamidi in njihova uporaba
GB0801319D0 (en) Compounds and their use
GB0807621D0 (en) Use
GB0813359D0 (en) Halfin and/or platerfin
GB0719834D0 (en) Compounds, method and use
GB0906434D0 (en) New use
PL383212A1 (pl) Nowa DD-karboksypeptydaza, jej otrzymywanie i zastosowania